drugset / Trial / NCT06816264
A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to evaluate the efficacy and safety of HRS-5346 in adult participants with elevated Lp(a) at high risk for cardiovascular events.
Timeline
- Start
- 2025-02-18
- Primary completion
- 2025-09-29
- Completion
- 2025-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-5346 | Unknown | — | Oral |
Indications
No indication recorded.